Morteza Eskandani, Elmira Dadizadeh, Hamed Hamishehkar, Hossein Nazemiyeh*, Jaleh Barar*
|
Balal Khalilzadeh, Nasrin Shadjou, Hadi Afsharan, Morteza Eskandani, Hojjatollah Nozad Charoudeh, Mohammad-Reza Rashidi*
|
Somayeh Vandghanooni, Morteza Eskandani*
|
Solmaz Asnaashari, Elmira Dadizadeh, Amir Hossein Talebpour, Morteza Eskandani, Hossein Nazemiyeh*
|
Mohammad Reza Asgharzadeh, Jaleh Barar , Mohammad M. Pourseif, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi*
|
Masumeh Zamanlu, Morteza Eskandani*, Reza Mohammadian, Nazila Entekhabi, Mohammad Rafi, Mehdi Farhoudi*
|
Ailar Nakhlband, Morteza Eskandani, Yadollah Omidi , Nazli Saeedi, Samad Ghafari, Jaleh Barar* , Alireza Garjani*
|
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar , Yadollah Omidi*
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
|
Mohammad Reza Asgharzadeh, Mohammad M. Pourseif, Jaleh Barar , Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi*
Increased expression of TSGA10 associated with the reduced metastasis in the MDA-MB-231 cells. TSGA10 showed interaction with HIF-1α with high affinity. TSGA10 expression is altered under the hypoxia, indicating its potential as a bio-target for cancer therapy.
|